These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8914427)

  • 1. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
    Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H
    Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorder of lipid metabolism in visceral fat syndrome--relation to familial combined hyperlipidemia].
    Ishigami M; Nakamura T; Matsuzawa Y
    Nihon Rinsho; 2002 May; 60(5):868-74. PubMed ID: 12029987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Syndrome X].
    Kotake H; Oikawa S
    Nihon Rinsho; 1999 Mar; 57(3):622-6. PubMed ID: 10199144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
    Juhan-Vague I; Alessi MC; Morange PE
    Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 14. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Life style-related disease].
    Matsuzawa Y
    Nihon Rinsho; 2001 Jan; 59(1):188-94. PubMed ID: 11197854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and pathogenesis of visceral fat obesity.
    Matsuzawa Y; Shimomura I; Nakamura T; Keno Y; Kotani K; Tokunaga K
    Obes Res; 1995 Sep; 3 Suppl 2():187S-194S. PubMed ID: 8581775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
    Lafontan M; Girard J
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.